Higher Upadacitinib Dose May Be Better for UC Maintenance

(MedPage Today) -- A higher daily dose of upadacitinib (Rinvoq) was associated with less severe disease and longer clinical remission for ulcerative colitis patients who responded to upadacitinib induction at 8 weeks, a post-hoc analysis of the...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news